Author(s):
Bailasan Hasan, Remal Asaad
Email(s):
bilasanhassan12@gmail.com
DOI:
10.52711/0974-360X.2023.00135 
Address:
Bailasan Hasan1*, Remal Asaad2
1Biochemistry and Microbiology Department, Faculty of Pharmacy, Tishreen University, Lattakia, Syria.
2Biochemistry and Microbiology Department, Faculty of Pharmacy,Tishreen University, Lattakia, Syria.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2023
ABSTRACT:
Metabolic Syndrome (MetS) is a rapidly growing public health problem worldwide and is significantly associated with poor cardiovascular outcomes. Increased visceral adiposity activates a low-grade chronic inflammatory state, oxidative stress, and blood coagulation. This study aimed to investigate the association of both white blood cell (WBC) and platelet counts, as inflammatory markers, with the presence and severity of MetS among T2DM patients.. The study was conducted on 117 adult patients with type 2 diabetes mellitus (T2DM) seen at Tishreen University Hospital (TUH) and Diabetes Center of Lattakia city in Syria. MetS was diagnosed according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III). The results showed a statistically significant increase in platelet counts in MetS patients compared to patients without MetS, and a statistically significant increase in WBC counts with increasing MetS components. There was a significant association between platelet counts and body mass index (BMI) (P=0.013), triglycerides levels (P=0.02), and glycated hemoglobin (HbA1C) (P=0.041). In conclusion, this study has demonstrated that high counts of WBCs and Platelets are associated with the prevalence and severity of Metabolic Syndrome (MetS).
Cite this article:
Bailasan Hasan, Remal Asaad. White Blood Cell and Platelet Counts as Simple and Inexpensive Markers for Determination the Metabolic Syndrome among patients with Type 2 Diabetes Mellitus. Research Journal of Pharmacy and Technology 2023; 16(2):786-0. doi: 10.52711/0974-360X.2023.00135
Cite(Electronic):
Bailasan Hasan, Remal Asaad. White Blood Cell and Platelet Counts as Simple and Inexpensive Markers for Determination the Metabolic Syndrome among patients with Type 2 Diabetes Mellitus. Research Journal of Pharmacy and Technology 2023; 16(2):786-0. doi: 10.52711/0974-360X.2023.00135 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2023-16-2-54
REFERENCES:
1. Akboga, M.K., et al., Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: A single center large-scale study. Platelets, 2016. 27(2): p. 178-83. doi: 10.3109/09537104.2015.1064518
2. Ibrahim, N.A., et al., Metabolic Syndrome associated Risk factors: Findings among female undergraduate university students. Research Journal of Pharmacy and Technology, 2020. 13(12): p. 6093-609. doi:10.5958/0974-360X.2020.01062.8
3. Kim, D.-J. and J.-H. Kim, Relationship between Cardiopulmonary function Metabolic Syndrome Indices. Research Journal of Pharmacy and Technology, 2017. 10(11): p. 3868-3872. doi: 10.5958/0974-360X.2017.00702.8
4. Mounika, S. and G. Savitha, Association of periodontal diseases and metabolic syndrome. Research Journal of Pharmacy and Technology, 2015. 8(8): p. 994-996. doi: 10.5958/0974-360X.2015.00166.3
5. Kassi, E., et al., Metabolic syndrome: definitions and controversies. BMC Medicine, 2011. 9(1): p. 48. https://doi.org/10.1186/1741-7015-9-48
6. Rao, U.M., et al., Assessment of Malaysian University undergraduate's knowledge and awareness on metabolic syndrome and conditions related to it. Research Journal of Pharmacy and Technology, 2021. 14(4): p. 1893-1898. doi: 10.52711/0974-360X.2021.00334
7. Kaur, J., A Comprehensive Review on Metabolic Syndrome. Cardiology Research and Practice, 2014. 2014: p. 943162. doi: 10.1155/2014/943162.
8. Hassan, N., et al., Association between serum liver enzymes and metabolic syndrome among type 2 diabetes mellitus patients. Age (years), 2021. 56(9.8): p. 59.83-9.5. doi: 10.5958/0974-360X.2021.00188.8
9. Shukri, N.M.M., et al., Awareness in childhood obesity. Research Journal of Pharmacy and Technology, 2016. 9(10): p. 1658. doi: 10.5958/0974-360X.2016.00334.6
10. Cinti, S., et al., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research, 2005. 46(11): p. 2347-2355. doi: 10.1194/jlr.M500294-JLR200.
11. Trayhurn, P. and I.S. Wood, Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr, 2004. 92(3): p. 347-55. doi: 10.1079/bjn20041213.
12. Francesco, D., R. Erica, and A. Walter, The metabolic syndrome and the risk of thrombosis. Haematologica, 2007. 92(3): p. 297-299. https://doi.org/10.3324/haematol.11243
13. Bhattacharya, K., et al., Pathophysiology of obesity: endocrine, inflammatory and neural regulators. Research Journal of Pharmacy and Technology, 2020. 13(9): p. 4469-4478. doi: 10.5958/0974-360X.2020.00789.1
14. Ibrahim, R., M.I. Khayat, and A. Zrieki, D Hypovitaminosis in Syrian Type 2 Diabetes Mellitus Patients: Lack of Relationship with Glycemic Control. Research Journal of Pharmacy and Technology, 2018. 11(12): p. 5319-5326. doi: 10.5958/0974-360X.2021.00188.8
15. Ambad, R., et al., Association of leptin in diabetes mellitus and obesity. Research Journal of Pharmacy and Technology, 2020. 13(12): p. 6295-6299. doi: 10.5958/0974-360X.2020.01095.1
16. Mohsen, H., et al., Correlation of serum leptin levels with insulin resistance in Syrian obese patients with type 2 diabetes mellitus. Research Journal of Pharmacy and Technology, 2013. 6(10): p. 1149-1151.
17. Jung, C.-H., et al., The risk of metabolic syndrome according to the white blood cell count in apparently healthy Korean adults. Yonsei medical journal, 2013. 54(3): p. 615-620. https://doi.org/10.3349%2Fymj.2013.54.3.615
18. Chen, L.K., et al., Association of insulin resistance and hematologic parameters: study of a middle-aged and elderly Chinese population in Taiwan. J Chin Med Assoc, 2006. 69(6): p. 248-53. https://doi.org/10.1016/s1726-4901(09)70251-5
19. Garrow, J.S. and J. Webster, Quetelet's index (W/H2) as a measure of fatness. Int J Obes, 1985. 9(2): p. 147-53.
20. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama, 2001. 285(19): p. 2486-97. https://doi.org/10.1001/jama.285.19.2486
21. Després, J.P., Abdominal obesity and cardiovascular disease: is inflammation the missing link? Can J Cardiol, 2012. 28(6): p. 642-52. https://doi.org/10.1016/j.cjca.2012.06.004
22. Fernández-Real, J.M. and W. Ricart, Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia, 1999. 42(11): p. 1367-74. https://doi.org/10.1007/s001250051451
23. Fernandez-Real, J.M., et al., Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab, 2001. 86(3): p. 1154-9. https://doi.org/10.1210/jcem.86.3.7305
24. Després, J.P., Is visceral obesity the cause of the metabolic syndrome? Ann Med, 2006. 38(1): p. 52-63. https://doi.org/10.1080/07853890500383895
25. Shim, W.S., et al., The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract, 2006. 73(3): p. 284-91. https://doi.org/10.1016/j.diabres.2006.02.001
26. Tao, L.X., et al., Association of hematological parameters with metabolic syndrome in Beijing adult population: a longitudinal study. Endocrine, 2014. 46(3): p. 485-95. https://doi.org/10.1007/s12020-013-0067-z
27. van Rooy, M.J. and E. Pretorius, Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke. Thromb Res, 2015. 135(3): p. 434-42. https://doi.org/10.1016/j.thromres.2014.12.030
28. Ross, R., Atherosclerosis--an inflammatory disease. N Engl J Med, 1999. 340(2): p. 115-26. https://doi.org/10.1056/nejm199901143400207
29. Wang, Y.Y., et al., Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complications, 2004. 18(6): p. 322-7. https://doi.org/10.1016/s1056-8727(04)00003-0
30. Lim, H.J., et al., The association between platelet count and metabolic syndrome in children and adolescents. Platelets, 2015. 26(8): p. 758-63. https://doi.org/10.3109/09537104.2014.995613
31. Kotani, K., et al., Clustered components of the metabolic syndrome and platelet counts in Japanese females. Clin Chem Lab Med, 2007. 45(3): p. 376-9. doi: 10.1515/CCLM.2007.06
32. Jesri, A., E.C. Okonofua, and B.M. Egan, Platelet and white blood cell counts are elevated in patients with the metabolic syndrome. Journal of clinical hypertension (Greenwich, Conn.), 2005. 7(12): p. 705-713. https://doi.org/10.1111%2Fj.1524-6175.2005.04809.x
33. Ding, Q., et al., The relationship between mean platelet volume and metabolic syndrome in patients with type 2 diabetes mellitus: A retrospective study. Medicine, 2021. 100(13): p. e25303-e25303. https://doi.org/10.1097%2FMD.0000000000025303
34. Yudkin, J.S., et al., Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis, 2000. 148(2): p. 209-14. https://doi.org/10.1016/s0021-9150(99)00463-3
35. Baatout, S., Interleukin-6 and megakaryocytopoiesis: an update. Ann Hematol, 1996. 73(4): p. 157-62. https://doi.org/10.1007/s002770050220
36. Jamshidi, L. and A. Seif, Association Between Obesity, White Blood Cell and Platelet Count. 2017. 19(2): p. e4955. https://dx.doi.org/%2010.5812/zjrms.4955
37. Chang, Y.-L., et al., Association Between Platelet Count and Components of Metabolic Syndrome in Geriatric Taiwanese Males. International Journal of Gerontology, 2012. 6(3): p. 215-219. https://doi.org/10.1016/j.ijge.2012.01.021
38. Demirtunc, R., et al., The relationship between glycemic control and platelet activity in type 2 diabetes mellitus. J Diabetes Complications, 2009. 23(2): p. 89-94. https://doi.org/10.1016/j.jdiacomp.2008.01.006
39. Bae, S.H., et al., Platelet activation in patients with diabetic retinopathy. Korean J Ophthalmol, 2003. 17(2): p. 140-4. https://doi.org/10.3341/kjo.2003.17.2.140
40. Saluja, M., Y.K. Swami, and S.R. Meena, Study of Impact of Glycemic Status (HbA1c) on Platelet Activity measured by Mean Platelet Volume & Vascular Complications in Diabetics. J Assoc Physicians India, 2019. 67(4): p. 26-29.
41. Zuberi, B.F., N. Akhtar, and S. Afsar, Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. Singapore Med J, 2008. 49(2): p. 114-6.